Product Images Verapamil Hci

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Verapamil Hci NDC 51662-1269 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Pouch Labeling - 00351662126929 Verapamil pouch label

Pouch Labeling - 00351662126929 Verapamil pouch label

Verapamil HCI Injection is a sterile and nonpyrogenic medical solution for intravenous use. It comes in 5mg/2mL (2.5mg/mL) vials, with each vial having an NDC code of 1662-1269-2 and a LOT number of 12545. The medicine should be protected from light and discarded if unused. The usual dosage can be found in the insert provided, and the medicine should be stored at a temperature of 20-25°C (68-77°F). This medicine is only for use with a prescription. It is manufactured by HF Acquisition Co., LLC in Mukilteo, WA 98275, with an original NDC code of 0409-1144-05.*

51662-1269-3 RFID Serialized Label - 00351662126936 Verapamil RFID label (1)

51662-1269-3 RFID Serialized Label - 00351662126936 Verapamil RFID label (1)

00351662126936 Verapamil Case label.jpg - 51662 1296 3 00351662126936 Verapamil Case label

00351662126936 Verapamil Case label.jpg - 51662 1296 3 00351662126936 Verapamil Case label

VERAPAMIL HCI INJECTION, USP Smg/2mL (2.5mg/mL) is a sterile, nonpyrogenic solution that comes in a 2mL vial box of 25. It is intended for intravenous use only and should be protected from light. The solution should be discarded if not used, and usual dosage should be seen on the insert. It should be stored in controlled room temperature (20°C to 25°C) and its expiration date is on 2025-01-01. The manufacturer's package insert can be referenced for more information. This product is prescription-only.*

ADVERSE - Adverse

ADVERSE - Adverse

This text provides information about various adverse reactions that can occur and their respective treatments. The frequency of these reactions is low, and experience with their treatment is limited. The treatments listed include intravenous administration of fluids, dopamine, calcium chloride, norepinephrine bitartrate, metaraminol bitartrate, isoproterenol HCl, atropine, cardiac pacing, DC-cardioversion, and various medications for rapid ventricular rates and arrhythmias. Bradycardia, AV block, and asystole are treated with intravenous fluids and calcium chloride. The text also mentions the use of lidocaine to treat certain conditions.*

LOGO - How Supplied Logo

LOGO - How Supplied Logo

HOW SUPPLIED - How supplied

HOW SUPPLIED - How supplied

SERIALIZED LABEL - serialized 51662 1269 1 Verapamil 2 1

SERIALIZED LABEL - serialized 51662 1269 1 Verapamil 2 1

STRUCTURE - structure

STRUCTURE - structure

VIAL - vial label

VIAL - vial label

This is a description of an injection labeled as USP, with a concentration of 5mg per 2ml (25mg/mL) identified by the drug code rL-7063. It is specifically designed for intravenous administration and should be protected from light. The manufacturer, Hospira Inc., is located in Lake Forest, Illinois, USA. The rest of the text is not relevant and appears to contain errors.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.